Search

Your search keyword '"Erythropoietin/*therapeutic use"' showing total 39 results

Search Constraints

Start Over You searched for: Descriptor "Erythropoietin/*therapeutic use" Remove constraint Descriptor: "Erythropoietin/*therapeutic use"
39 results on '"Erythropoietin/*therapeutic use"'

Search Results

1. Iron Deficiency in Heart Failure and Effect of Dapagliflozin : Findings From DAPA-HF.

2. Nouveautés dans la pathophysiologie et le traitement de l’anémie rénale [New insights in the pathophysiology and treatment of renal anemia]

Catalog

Books, media, physical & digital resources

3. Erytropoietin som mulig behandling ved hjernesygdom

4. Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants

5. Switch From Conventional to Every Other Day Hemodialysis: A Comparison Pilot Study

6. Phase I Trial of Intravenous Cisplatin-Topotecan Chemotherapy for Three Consecutive Days in Patients with Advanced Solid Tumors: Parallel Topotecan Escalation in Two Fixed Platinum Dosing Schemes

7. Alterations in body weight, breaking strength, and wound healing in Wistar rats treated pre- and postoperatively with erythropoietin or granulocyte macrophage–colony stimulating factor: Evidence of a previously unknown anabolic effect of erythropoietin?

8. Ferric carboxymaltose increases epoetin-alpha response and prevents iron deficiency before elective orthopaedic surgery

9. Beneficial effect of atorvastatin on erythropoietin responsiveness in maintenance haemodialysis patients

10. Erythropoietin reduces necrosis in critically ischemic myocutaneous tissue by protecting nutritive perfusion in a dose-dependent manner

11. Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance

12. The role of erythropoietin in central and peripheral nerve injury

13. Axonal regeneration stimulated by erythropoietin: an experimental study in rats

14. Role of Gas6 in erythropoiesis and anemia in mice

15. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model

16. External radiotherapy and anaemia treatment: state of the art

17. Recombinant human erythropoietin in a triplet pregnancy: a case report

18. Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome

19. Antierythropoietin antibodies in thalassemia patients

20. Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human erythropoietin (rHuEPO): A prospective, open label, randomized trial by the hellenic cooperative oncology group

21. Sicherheit von Eigenblutspende vor herzchirurgischen Eingriffen

22. Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients

23. Investigation for the presence of anti-erythropoietin antibodies in patients with myelodysplastic syndromes

24. Preliminary results of amifostine administration in combination with recombinant human erythropoietin in patients with myelodysplastic syndromes

25. Recombinant human erythropoietin therapy in a transfusion-dependent beta-thalassemia major patient

26. Effective treatment of beta-thalassemia intermedia during pregnancy with rHuEpo. A case report

27. Effect of recombinant human erythropoietin in preterm infants

28. Recombinant human erythropoietin treatment of postpartum anemia. Preliminary results

29. Recombinant human erythropoietin for the treatment of refractory anemia in lymphoproliferative disorders: preliminary results

30. Combined treatment with thalidomide, corticosteroids, and erythropoietin in patients with idiopathic myelofibrosis

31. Combination therapy with recombinant human erythropoietin, interferon-alpha-2b and granulocyte-macrophage colony-stimulating factor in idiopathic myelofibrosis

32. Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy

34. Pharmacokinetics of recombinant human erythropoietin applied subcutaneously to children with chronic renal failure

35. Murine autoimmune hemolytic anemia resulting from Fc gamma receptor-mediated erythrophagocytosis: protection by erythropoietin but not by interleukin-3, and aggravation by granulocyte-macrophage colony-stimulating factor

36. Interleukin 3 perfusion prevents death due to acute anemia induced by monoclonal antierythrocyte autoantibody

37. Treatment of MDS patients with recombinant human erythropoietin and the role of GSTs

38. Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients

39. Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity. European Randomized Multicenter Trial